95330 ⎘
Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
COMPOSITIONS FOR MODULATING SPLICING
#2COMPOSITIONS AND METHODS FOR PARASITE CONTROL
#3HPK1 antagonists and uses thereof
#4Pharmaceutical compounds
#5PRMT5 inhibitors
#6Imaging composition and uses thereof
#7Tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors
#8Imaging composition and uses thereof
#9Pharmaceutical compounds
#10Imaging composition and uses thereof
#11(1R,4R) 7-OXO-2-AZABICYCLO[2.2.2]OCT-5-ENE AND DERIVATIVES THEREOF
#12SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS
#13Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
#14TETRAHYDROISOQUINOLINES AS SELECTIVE NADPH OXIDASE 2 INHIBITORS
#15Imaging composition and uses thereof
#16Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#17STABLE CRYSTALLINE NORIBOGAINE SALT ANSOLVATES
#18NORIBOGAINE SALT TABLETS
#19Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#206-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
#21Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#22Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#23Tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors
#24Substituted noribogaine
#25Methods and compositions for preparing noribogaine from voacangine
#26Cyclic amine derivatives as EPreceptor antagonists
#27Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
#28Small molecule inducers of GDNF as potential new therapeutics for neuropsychiatric disorders
#29Pyrido[3,4-b] indoles and methods of use
#30Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
#316-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
#32Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#33N-substituted noribogaine prodrugs
#34Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
#35Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#36Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
#37Bicyclic amides for enhancing glutamatergic synaptic responses
#38Pyrido[4,3-B]indoles and methods of use
#39Pyrido[4,3-B]indoles and methods of use
#40Noribogaine salt ansolvates
#41Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#423-substituted sulfonyl piperidine derivative
#43Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
#44Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
#45Pyrido[4,3-b]indoles and methods of use
#46Bridged bicyclic RHO kinase inhibitor compounds, composition and use
#47SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS
#48Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
#49SOLUBLE EPOXIDE HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
#50Methods for the treatment of respiratory depression
#513-substituted sulfonyl piperidine derivative
#52Bicyclic amides for enhancing glutamatergic synaptic responses
#53Bridged six-membered ring compounds
#5411BETA-HSD1 ACTIVE COMPOUNDS
#55ISOQUINUCLIDINE DERIVATIVE AND METHOD FOR MANUFACTURING 1-CYCLOHEXENE-1-CARBOXYLIC ACID DERIVATIVE USING THE SAME
#56Benzimidazole quinolinones and uses thereof
#572-(cyclic amino)-pyrimidone derivatives
#58Npy antagonists, preparation and uses
#59Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
#60SUBSTITUTED THIOPHENES AND USES THEREOF
#61Novel Compounds 894
#622-aminobenzoxazole carboxamides as 5HT3 modulators
#63Alcohol oxidation catalyst and its preparation process
#64Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#65Pyrrolidine and related derivatives useful as PR modulators
#66Oxazolidone derivatives as PR modulators
#67Quinoline Tachykinin Receptor Antagonists
#68Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
#69Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#70Dibenzyl amine compounds and derivatives
#71Anti-inflammatory medicaments
#72Substitute thiophenes and uses thereof
#73Substituted pyrazoles
#74Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists
#75Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
#76Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists
#77Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists
#78Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
#79Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
#80Bicyclic and tricyclic amines as modulators of chemokine receptor activity
#81Substituted furo[2,3-b]pyridine derivatives
#82Novel compounds of proline and morpholine derivatives
#83Metabotropic glutamate receptor antagonists
#84Benzimidazole quinolinones and uses thereof
#85Pyridazinones as antagonists of alpha4 integrins
#86Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#87N-'4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
#88Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
#89Carboxylic acid amides
#90Semicarbazide derivatives for combating thromboembolic diseases
#91Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
#92Novel phenyl derivatives as inducers of apoptosis
#93Azabicyclo compound matrix metalloprotease inhibitor and skin preparation